» Authors » Jesse Gitaka

Jesse Gitaka

Explore the profile of Jesse Gitaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 779
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ko Y, Kagaya W, Chan C, Kanamori M, Mbugua S, Rotich A, et al.
BMJ Public Health . 2025 Feb; 2(2):e001557. PMID: 40018582
Objectives: There is an urgent need to maximise the effectiveness of existing malaria interventions and optimise the deployment of novel countermeasures. When assessing the effects of interventions against malaria, it...
2.
Owino F, Kijogi C, Anzala O, Walong E, Jael O, Nyanjom S, et al.
Front Immunol . 2025 Feb; 16:1497936. PMID: 40007543
Introduction: Macrophages play a crucial immunological role in maintaining pregnancy. Placental malaria infection may cause dysfunction in decidual macrophages which then culminates in the associated pregnancy complications. Here, we determined...
3.
Ko Y, Kagaya W, Yoneoka D, Kongere J, Opiyo V, Oginga J, et al.
Malar J . 2025 Feb; 24(1):42. PMID: 39939989
Background: Long-lasting insecticidal nets (LLIN) and vaccines are effective malaria control tools. However, inadequate uptake has been reported in countries where both interventions are available. To maximize the impact these...
4.
Shiluli C, Kamath S, Kanoi B, Kimani R, Oduor B, M Abkallo H, et al.
PLoS One . 2025 Feb; 20(2):e0317958. PMID: 39919090
Introduction: Annually, approximately 174 million people globally are affected by Trichomonas vaginalis (T. vaginalis) infection. Half of these infections occur in resource-limited regions. Untreated T. vaginalis infections are associated with...
5.
Ko Y, Kagaya W, Omondi P, Musyoka K, Okai T, Chan C, et al.
BMJ Open . 2025 Jan; 15(1):e087832. PMID: 39890133
Introduction: Malaria is still a major health problem in sub-Saharan Africa, where 98% of global malaria mortality occurs. In addition, the spread of with partial artemisinin resistance in East Africa...
6.
Maina M, Musundi S, Kuja J, Waweru H, Kiboi D, Kanoi B, et al.
Front Parasitol . 2025 Jan; 3():1346017. PMID: 39817167
The Circumsporozoite Protein (PfCSP) has been used in developing the RTS,S, and R21 malaria vaccines. However, genetic polymorphisms within compromise the effectiveness of the vaccine. Thus, it is essential to...
7.
Ally O, Kanoi B, Kamath S, Shiluli C, Ndombi E, Odiere M, et al.
Front Parasitol . 2025 Jan; 3():1361493. PMID: 39817162
Introduction: Schistosomiasis (Bilharzia), a neglected tropical disease caused by parasites, afflicts over 240 million people globally, disproportionately impacting Sub-Saharan Africa. Current diagnostic tests, despite their utility, suffer from limitations like...
8.
Kamita M, Maina M, Kimani R, Mwangi R, Mureithi D, Nduta C, et al.
Front Antibiot . 2025 Jan; 1():993271. PMID: 39816410
Antibiotic resistance causes higher morbidity and mortality and higher healthcare costs. One of the factors influencing the emergence of antibiotic resistance is the inappropriate use of antibiotics. Clinical practitioners' incorrect...
9.
Okai T, Chan C, Kc A, Omondi P, Musyoka K, Kongere J, et al.
Trop Med Health . 2024 Dec; 52(1):94. PMID: 39696727
Malaria rapid diagnostic tests (RDTs) targeting the Plasmodium falciparum histidine-rich protein 2 (PfHRP2) are widely used to diagnose P. falciparum infection. However, reports of P. falciparum strains lacking PfHRP2 and...
10.
Makau M, Kanoi B, Mgawe C, Maina M, Bitshi M, Too E, et al.
Trop Med Health . 2024 Oct; 52(1):72. PMID: 39425178
Malaria remains a key health and economic problem, particularly in sub-Saharan Africa. The emergence of artemisinin drug resistance (ART-R) parasite strains poses a serious threat to the control and elimination...